Predictive and prognostic significance of M descriptors of the 8th TNM classification for advanced NSCLC patients treated with immune checkpoint inhibitors-Reference-Cited by-同舟云学术

Predictive and prognostic significance of M descriptors of the 8th TNM classification for advanced NSCLC patients treated with immune checkpoint inhibitors

Published:2020-08 Issue:4 Volume:9 Page:1053-1066
ISSN:2218-6751
Container-title:Translational Lung Cancer Research
language:
Short-container-title:Transl Lung Cancer Res

Author:

Liu Sangtian,Zhou Fei,Liu Zhiyu,Xiong Anwen,Jia Yijun,Zhao Sha,Zhao Chao,Li Xuefei,Jiang Tao,Han Ruoshuang,Qiao Meng,Liu Yiwei,He Yayi,Li Jiayu,Li Wei,Gao Guanghui,Ren Shengxiang,Su Chunxia,Zhou Caicun

Publisher

AME Publishing Company

Subject

Oncology

Link

http://tlcr.amegroups.com/article/download/41654/pdf

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-World Analysis of Post-Progression Treatment Patterns and Outcomes for EGFR Mutation-Positive Patients Treated with First-Line Osimertinib;Current Oncology;2024-04-26

2. Modelled mortality benefits of multi-cancer early detection screening in England;British Journal of Cancer;2023-04-25

3. Pembrolizumab plus pemetrexed-carboplatin combination in first-line treatment of advanced non-squamous non-small cell lung cancer: a multicenter real-life study (CAP29);Translational Lung Cancer Research;2023-02

4. Construction and Validation of Two Novel Nomograms for Predicting the Overall Survival and Cancer-Specific Survival of NSCLC Patients with Bone Metastasis;International Journal of General Medicine;2021-12

5. Pemetrexed plus platinum with or without pembrolizumab in patients with previously untreated metastatic nonsquamous NSCLC: protocol-specified final analysis from KEYNOTE-189;Annals of Oncology;2021-07